Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Jason Shofnos

Thoracic Surgery (Cardiothoracic Vascular Surgery) Denver, CO Medical Doctor

NPI 1497821292 CMS profile 203220

1960 Ogden St, Suite 540, Denver, CO 80218

Open in the dashboard

General payments

$40,259

203 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jason Shofnos of Denver, CO is reported in the CMS Open Payments database as having received $40,259 across 203 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 88th percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $19,785 69
2024 General $11,401 40
2023 General $1,226 15
2022 General $3,760 33
2021 General $558 13
2020 General $621 9
2019 General $2,908 24

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jason Shofnos
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Jason Shofnos were reported at $19,785. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Jason Shofnos Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $2,908 $886 $178–$3,167 $163
2020 $621 $341 $108–$1,605 $114
2021 $558 $453 $125–$1,886 $132
2022 $3,760 $695 $180–$2,566 $149
2023 $1,226 $745 $205–$2,662 $160
2024 $11,401 $799 $214–$2,967 $164
2025 $19,785 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Edwards Lifesciences Corporation $28,104 97 payments
  2. CryoLife, Inc. $4,083 26 payments
  3. Abiomed $3,389 29 payments
  4. Atricure, Inc. $1,643 12 payments
  5. Abbott Laboratories $900 14 payments
  6. Boston Scientific Corporation $567 4 payments
  7. Zimmer Biomet Holdings, Inc. $384 3 payments
  8. Bolton Medical Inc $262 2 payments
  9. Medtronic, Inc. $237 3 payments
  10. W. L. Gore & Associates, Inc. $225 2 payments
  11. Other $465 11 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $19,080 3 payments
  2. Food and Beverage $12,279 167 payments
  3. Travel and Lodging $8,901 33 payments
Products named General payments · program years 2019–2025
  1. EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) $20,843 20 payments
  2. Impella $2,885 22 payments
  3. SAPIEN 3 Ultra RESILIA $1,979 15 payments
  4. AMDS-Ascyrus Medical $1,748 6 payments
  5. On-X $1,704 11 payments
  6. EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX $1,473 6 payments
  7. ON-X AORTIC HEART VALVE WITH CONFORM-X SEWING RING AND EXTENDED HOLDER $727 9 payments
  8. KONECT RESILIA $581 7 payments
  9. General Therapies $567 4 payments
  10. EPIC $470 5 payments
  11. Other $4,330 73 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 33 billing codes

Paid by Medicare

$99,441

Medicare's payments for the services billed

Medicare patients

124

Average age 77

Services billed

223

42 women, 82 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Atrial fibrillation 49%
Heart failure 48%
Arthritis 44%
Chronic kidney disease 34%
Diabetes 31%
Depression 27%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

203 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in Colorado

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record